nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—TERT—pancreatic cancer	0.382	1	CbGaD
Zidovudine—SLC28A1—Gemcitabine—pancreatic cancer	0.123	0.272	CbGbCtD
Zidovudine—SLC29A2—Gemcitabine—pancreatic cancer	0.082	0.181	CbGbCtD
Zidovudine—ABCC5—Fluorouracil—pancreatic cancer	0.0308	0.0679	CbGbCtD
Zidovudine—UGT2B7—Epirubicin—pancreatic cancer	0.0179	0.0395	CbGbCtD
Zidovudine—SLC22A7—Fluorouracil—pancreatic cancer	0.0151	0.0334	CbGbCtD
Zidovudine—ABCC4—Fluorouracil—pancreatic cancer	0.0148	0.0326	CbGbCtD
Zidovudine—CYP2A6—Tamoxifen—pancreatic cancer	0.0117	0.0257	CbGbCtD
Zidovudine—SLC22A7—Docetaxel—pancreatic cancer	0.0116	0.0255	CbGbCtD
Zidovudine—ABCC4—Sunitinib—pancreatic cancer	0.0112	0.0248	CbGbCtD
Zidovudine—ABCG2—Tamoxifen—pancreatic cancer	0.0108	0.0238	CbGbCtD
Zidovudine—ABCG2—Erlotinib—pancreatic cancer	0.00917	0.0202	CbGbCtD
Zidovudine—CYP2A6—Fluorouracil—pancreatic cancer	0.00859	0.019	CbGbCtD
Zidovudine—ABCG2—Irinotecan—pancreatic cancer	0.00828	0.0183	CbGbCtD
Zidovudine—ABCG2—Fluorouracil—pancreatic cancer	0.00795	0.0175	CbGbCtD
Zidovudine—ALB—Erlotinib—pancreatic cancer	0.00632	0.014	CbGbCtD
Zidovudine—ABCG2—Docetaxel—pancreatic cancer	0.00607	0.0134	CbGbCtD
Zidovudine—ABCG2—Sunitinib—pancreatic cancer	0.00604	0.0133	CbGbCtD
Zidovudine—CYP2C8—Tamoxifen—pancreatic cancer	0.00575	0.0127	CbGbCtD
Zidovudine—ALB—Irinotecan—pancreatic cancer	0.00571	0.0126	CbGbCtD
Zidovudine—ALB—Fluorouracil—pancreatic cancer	0.00548	0.0121	CbGbCtD
Zidovudine—CYP2C8—Erlotinib—pancreatic cancer	0.00488	0.0108	CbGbCtD
Zidovudine—CYP2C19—Tamoxifen—pancreatic cancer	0.00482	0.0106	CbGbCtD
Zidovudine—ABCG2—Doxorubicin—pancreatic cancer	0.00452	0.00999	CbGbCtD
Zidovudine—CYP2C8—Fluorouracil—pancreatic cancer	0.00423	0.00934	CbGbCtD
Zidovudine—CYP2C9—Tamoxifen—pancreatic cancer	0.00401	0.00884	CbGbCtD
Zidovudine—ABCB1—Tamoxifen—pancreatic cancer	0.00389	0.00858	CbGbCtD
Zidovudine—ABCB1—Gemcitabine—pancreatic cancer	0.00335	0.00739	CbGbCtD
Zidovudine—ABCB1—Erlotinib—pancreatic cancer	0.00331	0.0073	CbGbCtD
Zidovudine—ABCB1—Irinotecan—pancreatic cancer	0.00299	0.00659	CbGbCtD
Zidovudine—CYP2C9—Fluorouracil—pancreatic cancer	0.00295	0.00652	CbGbCtD
Zidovudine—CYP3A4—Tamoxifen—pancreatic cancer	0.00233	0.00514	CbGbCtD
Zidovudine—ABCB1—Docetaxel—pancreatic cancer	0.00219	0.00483	CbGbCtD
Zidovudine—ABCB1—Sunitinib—pancreatic cancer	0.00218	0.00481	CbGbCtD
Zidovudine—CYP3A4—Erlotinib—pancreatic cancer	0.00198	0.00437	CbGbCtD
Zidovudine—CYP3A4—Irinotecan—pancreatic cancer	0.00179	0.00395	CbGbCtD
Zidovudine—ABCB1—Doxorubicin—pancreatic cancer	0.00163	0.0036	CbGbCtD
Zidovudine—Floxuridine—TYMP—pancreatic cancer	0.00147	0.379	CrCbGaD
Zidovudine—CYP3A4—Docetaxel—pancreatic cancer	0.00131	0.00289	CbGbCtD
Zidovudine—CYP3A4—Sunitinib—pancreatic cancer	0.00131	0.00288	CbGbCtD
Zidovudine—Trifluridine—TYMP—pancreatic cancer	0.00117	0.301	CrCbGaD
Zidovudine—TK1—Azacitidine—Gemcitabine—pancreatic cancer	0.00109	1	CbGdCrCtD
Zidovudine—CYP3A4—Doxorubicin—pancreatic cancer	0.000977	0.00216	CbGbCtD
Zidovudine—Floxuridine—TYMS—pancreatic cancer	0.000692	0.178	CrCbGaD
Zidovudine—Trifluridine—TYMS—pancreatic cancer	0.00055	0.142	CrCbGaD
Zidovudine—Breast disorder—Doxorubicin—pancreatic cancer	6.79e-05	0.000761	CcSEcCtD
Zidovudine—Abdominal pain—Irinotecan—pancreatic cancer	6.77e-05	0.000758	CcSEcCtD
Zidovudine—Body temperature increased—Irinotecan—pancreatic cancer	6.77e-05	0.000758	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	6.77e-05	0.000758	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	6.77e-05	0.000758	CcSEcCtD
Zidovudine—Feeling abnormal—Fluorouracil—pancreatic cancer	6.76e-05	0.000757	CcSEcCtD
Zidovudine—Nasopharyngitis—Doxorubicin—pancreatic cancer	6.72e-05	0.000753	CcSEcCtD
Zidovudine—Anaemia—Docetaxel—pancreatic cancer	6.7e-05	0.000751	CcSEcCtD
Zidovudine—Pancytopenia—Epirubicin—pancreatic cancer	6.66e-05	0.000747	CcSEcCtD
Zidovudine—Vomiting—Sunitinib—pancreatic cancer	6.61e-05	0.000741	CcSEcCtD
Zidovudine—Body temperature increased—Gemcitabine—pancreatic cancer	6.59e-05	0.000739	CcSEcCtD
Zidovudine—Dysuria—Epirubicin—pancreatic cancer	6.56e-05	0.000736	CcSEcCtD
Zidovudine—Neutropenia—Epirubicin—pancreatic cancer	6.56e-05	0.000736	CcSEcCtD
Zidovudine—Rash—Sunitinib—pancreatic cancer	6.55e-05	0.000734	CcSEcCtD
Zidovudine—Dermatitis—Sunitinib—pancreatic cancer	6.55e-05	0.000734	CcSEcCtD
Zidovudine—Urticaria—Fluorouracil—pancreatic cancer	6.51e-05	0.00073	CcSEcCtD
Zidovudine—Headache—Sunitinib—pancreatic cancer	6.51e-05	0.00073	CcSEcCtD
Zidovudine—Syncope—Docetaxel—pancreatic cancer	6.5e-05	0.000729	CcSEcCtD
Zidovudine—Influenza—Doxorubicin—pancreatic cancer	6.49e-05	0.000728	CcSEcCtD
Zidovudine—Dysphagia—Doxorubicin—pancreatic cancer	6.49e-05	0.000728	CcSEcCtD
Zidovudine—Leukopenia—Docetaxel—pancreatic cancer	6.49e-05	0.000727	CcSEcCtD
Zidovudine—Pollakiuria—Epirubicin—pancreatic cancer	6.48e-05	0.000727	CcSEcCtD
Zidovudine—Body temperature increased—Fluorouracil—pancreatic cancer	6.48e-05	0.000726	CcSEcCtD
Zidovudine—Loss of consciousness—Docetaxel—pancreatic cancer	6.37e-05	0.000714	CcSEcCtD
Zidovudine—Pancreatitis—Doxorubicin—pancreatic cancer	6.37e-05	0.000714	CcSEcCtD
Zidovudine—Weight decreased—Epirubicin—pancreatic cancer	6.35e-05	0.000712	CcSEcCtD
Zidovudine—Cough—Docetaxel—pancreatic cancer	6.33e-05	0.000709	CcSEcCtD
Zidovudine—Convulsion—Docetaxel—pancreatic cancer	6.28e-05	0.000704	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	6.2e-05	0.000695	CcSEcCtD
Zidovudine—Arthralgia—Docetaxel—pancreatic cancer	6.17e-05	0.000692	CcSEcCtD
Zidovudine—Chest pain—Docetaxel—pancreatic cancer	6.17e-05	0.000692	CcSEcCtD
Zidovudine—Myalgia—Docetaxel—pancreatic cancer	6.17e-05	0.000692	CcSEcCtD
Zidovudine—Nausea—Sunitinib—pancreatic cancer	6.17e-05	0.000692	CcSEcCtD
Zidovudine—Pancytopenia—Doxorubicin—pancreatic cancer	6.17e-05	0.000691	CcSEcCtD
Zidovudine—Asthenia—Irinotecan—pancreatic cancer	6.14e-05	0.000688	CcSEcCtD
Zidovudine—Neuropathy peripheral—Epirubicin—pancreatic cancer	6.13e-05	0.000688	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	6.13e-05	0.000687	CcSEcCtD
Zidovudine—Stomatitis—Epirubicin—pancreatic cancer	6.1e-05	0.000684	CcSEcCtD
Zidovudine—Jaundice—Epirubicin—pancreatic cancer	6.1e-05	0.000684	CcSEcCtD
Zidovudine—Dysuria—Doxorubicin—pancreatic cancer	6.07e-05	0.000681	CcSEcCtD
Zidovudine—Neutropenia—Doxorubicin—pancreatic cancer	6.07e-05	0.000681	CcSEcCtD
Zidovudine—Sweating—Epirubicin—pancreatic cancer	6e-05	0.000672	CcSEcCtD
Zidovudine—Pollakiuria—Doxorubicin—pancreatic cancer	6e-05	0.000672	CcSEcCtD
Zidovudine—Asthenia—Gemcitabine—pancreatic cancer	5.98e-05	0.000671	CcSEcCtD
Zidovudine—Haematuria—Epirubicin—pancreatic cancer	5.97e-05	0.000669	CcSEcCtD
Zidovudine—Confusional state—Docetaxel—pancreatic cancer	5.97e-05	0.000669	CcSEcCtD
Zidovudine—Hepatobiliary disease—Epirubicin—pancreatic cancer	5.92e-05	0.000663	CcSEcCtD
Zidovudine—Oedema—Docetaxel—pancreatic cancer	5.92e-05	0.000663	CcSEcCtD
Zidovudine—Anaphylactic shock—Docetaxel—pancreatic cancer	5.92e-05	0.000663	CcSEcCtD
Zidovudine—Epistaxis—Epirubicin—pancreatic cancer	5.9e-05	0.000662	CcSEcCtD
Zidovudine—Pruritus—Gemcitabine—pancreatic cancer	5.9e-05	0.000661	CcSEcCtD
Zidovudine—Weight decreased—Doxorubicin—pancreatic cancer	5.87e-05	0.000658	CcSEcCtD
Zidovudine—Sinusitis—Epirubicin—pancreatic cancer	5.87e-05	0.000658	CcSEcCtD
Zidovudine—Diarrhoea—Irinotecan—pancreatic cancer	5.86e-05	0.000656	CcSEcCtD
Zidovudine—Agranulocytosis—Epirubicin—pancreatic cancer	5.84e-05	0.000655	CcSEcCtD
Zidovudine—Shock—Docetaxel—pancreatic cancer	5.82e-05	0.000652	CcSEcCtD
Zidovudine—Nervous system disorder—Docetaxel—pancreatic cancer	5.8e-05	0.00065	CcSEcCtD
Zidovudine—Pruritus—Fluorouracil—pancreatic cancer	5.8e-05	0.00065	CcSEcCtD
Zidovudine—Thrombocytopenia—Docetaxel—pancreatic cancer	5.79e-05	0.000649	CcSEcCtD
Zidovudine—Skin disorder—Docetaxel—pancreatic cancer	5.75e-05	0.000644	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	5.74e-05	0.000643	CcSEcCtD
Zidovudine—Diarrhoea—Gemcitabine—pancreatic cancer	5.7e-05	0.000639	CcSEcCtD
Zidovudine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	5.68e-05	0.000636	CcSEcCtD
Zidovudine—Dizziness—Irinotecan—pancreatic cancer	5.66e-05	0.000634	CcSEcCtD
Zidovudine—Stomatitis—Doxorubicin—pancreatic cancer	5.64e-05	0.000633	CcSEcCtD
Zidovudine—Jaundice—Doxorubicin—pancreatic cancer	5.64e-05	0.000633	CcSEcCtD
Zidovudine—Anorexia—Docetaxel—pancreatic cancer	5.64e-05	0.000632	CcSEcCtD
Zidovudine—Rhinitis—Epirubicin—pancreatic cancer	5.63e-05	0.000631	CcSEcCtD
Zidovudine—Hepatitis—Epirubicin—pancreatic cancer	5.62e-05	0.00063	CcSEcCtD
Zidovudine—Diarrhoea—Fluorouracil—pancreatic cancer	5.61e-05	0.000629	CcSEcCtD
Zidovudine—Pharyngitis—Epirubicin—pancreatic cancer	5.58e-05	0.000625	CcSEcCtD
Zidovudine—Sweating—Doxorubicin—pancreatic cancer	5.55e-05	0.000622	CcSEcCtD
Zidovudine—Urinary tract disorder—Epirubicin—pancreatic cancer	5.55e-05	0.000622	CcSEcCtD
Zidovudine—Haematuria—Doxorubicin—pancreatic cancer	5.52e-05	0.000619	CcSEcCtD
Zidovudine—Connective tissue disorder—Epirubicin—pancreatic cancer	5.52e-05	0.000619	CcSEcCtD
Zidovudine—Urethral disorder—Epirubicin—pancreatic cancer	5.51e-05	0.000617	CcSEcCtD
Zidovudine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	5.48e-05	0.000614	CcSEcCtD
Zidovudine—Epistaxis—Doxorubicin—pancreatic cancer	5.46e-05	0.000612	CcSEcCtD
Zidovudine—Vomiting—Irinotecan—pancreatic cancer	5.44e-05	0.00061	CcSEcCtD
Zidovudine—Sinusitis—Doxorubicin—pancreatic cancer	5.43e-05	0.000609	CcSEcCtD
Zidovudine—Dizziness—Fluorouracil—pancreatic cancer	5.42e-05	0.000608	CcSEcCtD
Zidovudine—Agranulocytosis—Doxorubicin—pancreatic cancer	5.4e-05	0.000606	CcSEcCtD
Zidovudine—Rash—Irinotecan—pancreatic cancer	5.4e-05	0.000605	CcSEcCtD
Zidovudine—Dermatitis—Irinotecan—pancreatic cancer	5.39e-05	0.000604	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	5.39e-05	0.000604	CcSEcCtD
Zidovudine—Headache—Irinotecan—pancreatic cancer	5.36e-05	0.000601	CcSEcCtD
Zidovudine—Insomnia—Docetaxel—pancreatic cancer	5.35e-05	0.0006	CcSEcCtD
Zidovudine—Paraesthesia—Docetaxel—pancreatic cancer	5.31e-05	0.000596	CcSEcCtD
Zidovudine—Erythema multiforme—Epirubicin—pancreatic cancer	5.31e-05	0.000595	CcSEcCtD
Zidovudine—Vomiting—Gemcitabine—pancreatic cancer	5.3e-05	0.000594	CcSEcCtD
Zidovudine—Dyspnoea—Docetaxel—pancreatic cancer	5.27e-05	0.000591	CcSEcCtD
Zidovudine—Somnolence—Docetaxel—pancreatic cancer	5.26e-05	0.00059	CcSEcCtD
Zidovudine—Rash—Gemcitabine—pancreatic cancer	5.26e-05	0.000589	CcSEcCtD
Zidovudine—Dermatitis—Gemcitabine—pancreatic cancer	5.25e-05	0.000589	CcSEcCtD
Zidovudine—Headache—Gemcitabine—pancreatic cancer	5.22e-05	0.000585	CcSEcCtD
Zidovudine—Cardiac disorder—Epirubicin—pancreatic cancer	5.21e-05	0.000584	CcSEcCtD
Zidovudine—Vomiting—Fluorouracil—pancreatic cancer	5.21e-05	0.000584	CcSEcCtD
Zidovudine—Rhinitis—Doxorubicin—pancreatic cancer	5.21e-05	0.000584	CcSEcCtD
Zidovudine—Dyspepsia—Docetaxel—pancreatic cancer	5.21e-05	0.000584	CcSEcCtD
Zidovudine—Hepatitis—Doxorubicin—pancreatic cancer	5.2e-05	0.000583	CcSEcCtD
Zidovudine—Rash—Fluorouracil—pancreatic cancer	5.17e-05	0.000579	CcSEcCtD
Zidovudine—Dermatitis—Fluorouracil—pancreatic cancer	5.16e-05	0.000579	CcSEcCtD
Zidovudine—Pharyngitis—Doxorubicin—pancreatic cancer	5.16e-05	0.000578	CcSEcCtD
Zidovudine—Decreased appetite—Docetaxel—pancreatic cancer	5.14e-05	0.000577	CcSEcCtD
Zidovudine—Headache—Fluorouracil—pancreatic cancer	5.14e-05	0.000576	CcSEcCtD
Zidovudine—Urinary tract disorder—Doxorubicin—pancreatic cancer	5.13e-05	0.000575	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	5.11e-05	0.000573	CcSEcCtD
Zidovudine—Connective tissue disorder—Doxorubicin—pancreatic cancer	5.11e-05	0.000572	CcSEcCtD
Zidovudine—Fatigue—Docetaxel—pancreatic cancer	5.1e-05	0.000572	CcSEcCtD
Zidovudine—Urethral disorder—Doxorubicin—pancreatic cancer	5.09e-05	0.000571	CcSEcCtD
Zidovudine—Nausea—Irinotecan—pancreatic cancer	5.08e-05	0.00057	CcSEcCtD
Zidovudine—Mediastinal disorder—Epirubicin—pancreatic cancer	5.06e-05	0.000567	CcSEcCtD
Zidovudine—Pain—Docetaxel—pancreatic cancer	5.06e-05	0.000567	CcSEcCtD
Zidovudine—Constipation—Docetaxel—pancreatic cancer	5.06e-05	0.000567	CcSEcCtD
Zidovudine—Chills—Epirubicin—pancreatic cancer	5.04e-05	0.000565	CcSEcCtD
Zidovudine—Nausea—Gemcitabine—pancreatic cancer	4.95e-05	0.000555	CcSEcCtD
Zidovudine—Mental disorder—Epirubicin—pancreatic cancer	4.92e-05	0.000552	CcSEcCtD
Zidovudine—Erythema multiforme—Doxorubicin—pancreatic cancer	4.91e-05	0.000551	CcSEcCtD
Zidovudine—Malnutrition—Epirubicin—pancreatic cancer	4.89e-05	0.000548	CcSEcCtD
Zidovudine—Erythema—Epirubicin—pancreatic cancer	4.89e-05	0.000548	CcSEcCtD
Zidovudine—Feeling abnormal—Docetaxel—pancreatic cancer	4.88e-05	0.000547	CcSEcCtD
Zidovudine—Nausea—Fluorouracil—pancreatic cancer	4.87e-05	0.000546	CcSEcCtD
Zidovudine—Gastrointestinal pain—Docetaxel—pancreatic cancer	4.84e-05	0.000542	CcSEcCtD
Zidovudine—Cardiac disorder—Doxorubicin—pancreatic cancer	4.82e-05	0.000541	CcSEcCtD
Zidovudine—Flatulence—Epirubicin—pancreatic cancer	4.82e-05	0.00054	CcSEcCtD
Zidovudine—Tension—Epirubicin—pancreatic cancer	4.8e-05	0.000538	CcSEcCtD
Zidovudine—Dysgeusia—Epirubicin—pancreatic cancer	4.79e-05	0.000537	CcSEcCtD
Zidovudine—Nervousness—Epirubicin—pancreatic cancer	4.75e-05	0.000532	CcSEcCtD
Zidovudine—Back pain—Epirubicin—pancreatic cancer	4.73e-05	0.00053	CcSEcCtD
Zidovudine—Muscle spasms—Epirubicin—pancreatic cancer	4.7e-05	0.000527	CcSEcCtD
Zidovudine—Mediastinal disorder—Doxorubicin—pancreatic cancer	4.68e-05	0.000525	CcSEcCtD
Zidovudine—Body temperature increased—Docetaxel—pancreatic cancer	4.68e-05	0.000524	CcSEcCtD
Zidovudine—Abdominal pain—Docetaxel—pancreatic cancer	4.68e-05	0.000524	CcSEcCtD
Zidovudine—Chills—Doxorubicin—pancreatic cancer	4.66e-05	0.000523	CcSEcCtD
Zidovudine—Mental disorder—Doxorubicin—pancreatic cancer	4.55e-05	0.00051	CcSEcCtD
Zidovudine—Ill-defined disorder—Epirubicin—pancreatic cancer	4.54e-05	0.000509	CcSEcCtD
Zidovudine—Erythema—Doxorubicin—pancreatic cancer	4.52e-05	0.000507	CcSEcCtD
Zidovudine—Malnutrition—Doxorubicin—pancreatic cancer	4.52e-05	0.000507	CcSEcCtD
Zidovudine—Anaemia—Epirubicin—pancreatic cancer	4.52e-05	0.000507	CcSEcCtD
Zidovudine—Flatulence—Doxorubicin—pancreatic cancer	4.46e-05	0.0005	CcSEcCtD
Zidovudine—Tension—Doxorubicin—pancreatic cancer	4.44e-05	0.000498	CcSEcCtD
Zidovudine—Dysgeusia—Doxorubicin—pancreatic cancer	4.43e-05	0.000497	CcSEcCtD
Zidovudine—Malaise—Epirubicin—pancreatic cancer	4.41e-05	0.000494	CcSEcCtD
Zidovudine—Nervousness—Doxorubicin—pancreatic cancer	4.39e-05	0.000493	CcSEcCtD
Zidovudine—Vertigo—Epirubicin—pancreatic cancer	4.39e-05	0.000492	CcSEcCtD
Zidovudine—Syncope—Epirubicin—pancreatic cancer	4.39e-05	0.000492	CcSEcCtD
Zidovudine—Leukopenia—Epirubicin—pancreatic cancer	4.38e-05	0.000491	CcSEcCtD
Zidovudine—Back pain—Doxorubicin—pancreatic cancer	4.38e-05	0.000491	CcSEcCtD
Zidovudine—Muscle spasms—Doxorubicin—pancreatic cancer	4.35e-05	0.000488	CcSEcCtD
Zidovudine—Loss of consciousness—Epirubicin—pancreatic cancer	4.3e-05	0.000482	CcSEcCtD
Zidovudine—Cough—Epirubicin—pancreatic cancer	4.27e-05	0.000478	CcSEcCtD
Zidovudine—Asthenia—Docetaxel—pancreatic cancer	4.25e-05	0.000476	CcSEcCtD
Zidovudine—Convulsion—Epirubicin—pancreatic cancer	4.24e-05	0.000475	CcSEcCtD
Zidovudine—Ill-defined disorder—Doxorubicin—pancreatic cancer	4.2e-05	0.000471	CcSEcCtD
Zidovudine—Pruritus—Docetaxel—pancreatic cancer	4.19e-05	0.000469	CcSEcCtD
Zidovudine—Anaemia—Doxorubicin—pancreatic cancer	4.18e-05	0.000469	CcSEcCtD
Zidovudine—Arthralgia—Epirubicin—pancreatic cancer	4.16e-05	0.000467	CcSEcCtD
Zidovudine—Myalgia—Epirubicin—pancreatic cancer	4.16e-05	0.000467	CcSEcCtD
Zidovudine—Chest pain—Epirubicin—pancreatic cancer	4.16e-05	0.000467	CcSEcCtD
Zidovudine—Anxiety—Epirubicin—pancreatic cancer	4.15e-05	0.000465	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	4.13e-05	0.000463	CcSEcCtD
Zidovudine—Discomfort—Epirubicin—pancreatic cancer	4.11e-05	0.000461	CcSEcCtD
Zidovudine—Malaise—Doxorubicin—pancreatic cancer	4.08e-05	0.000457	CcSEcCtD
Zidovudine—Vertigo—Doxorubicin—pancreatic cancer	4.06e-05	0.000456	CcSEcCtD
Zidovudine—Syncope—Doxorubicin—pancreatic cancer	4.06e-05	0.000455	CcSEcCtD
Zidovudine—Leukopenia—Doxorubicin—pancreatic cancer	4.05e-05	0.000454	CcSEcCtD
Zidovudine—Diarrhoea—Docetaxel—pancreatic cancer	4.05e-05	0.000454	CcSEcCtD
Zidovudine—Confusional state—Epirubicin—pancreatic cancer	4.02e-05	0.000451	CcSEcCtD
Zidovudine—Anaphylactic shock—Epirubicin—pancreatic cancer	3.99e-05	0.000447	CcSEcCtD
Zidovudine—Oedema—Epirubicin—pancreatic cancer	3.99e-05	0.000447	CcSEcCtD
Zidovudine—Loss of consciousness—Doxorubicin—pancreatic cancer	3.98e-05	0.000446	CcSEcCtD
Zidovudine—Cough—Doxorubicin—pancreatic cancer	3.95e-05	0.000443	CcSEcCtD
Zidovudine—Shock—Epirubicin—pancreatic cancer	3.93e-05	0.00044	CcSEcCtD
Zidovudine—Convulsion—Doxorubicin—pancreatic cancer	3.92e-05	0.000439	CcSEcCtD
Zidovudine—Nervous system disorder—Epirubicin—pancreatic cancer	3.91e-05	0.000439	CcSEcCtD
Zidovudine—Dizziness—Docetaxel—pancreatic cancer	3.91e-05	0.000439	CcSEcCtD
Zidovudine—Thrombocytopenia—Epirubicin—pancreatic cancer	3.91e-05	0.000438	CcSEcCtD
Zidovudine—Skin disorder—Epirubicin—pancreatic cancer	3.88e-05	0.000434	CcSEcCtD
Zidovudine—Hyperhidrosis—Epirubicin—pancreatic cancer	3.86e-05	0.000432	CcSEcCtD
Zidovudine—Myalgia—Doxorubicin—pancreatic cancer	3.85e-05	0.000432	CcSEcCtD
Zidovudine—Chest pain—Doxorubicin—pancreatic cancer	3.85e-05	0.000432	CcSEcCtD
Zidovudine—Arthralgia—Doxorubicin—pancreatic cancer	3.85e-05	0.000432	CcSEcCtD
Zidovudine—Anxiety—Doxorubicin—pancreatic cancer	3.84e-05	0.00043	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	3.83e-05	0.000429	CcSEcCtD
Zidovudine—Discomfort—Doxorubicin—pancreatic cancer	3.81e-05	0.000427	CcSEcCtD
Zidovudine—Anorexia—Epirubicin—pancreatic cancer	3.8e-05	0.000426	CcSEcCtD
Zidovudine—Vomiting—Docetaxel—pancreatic cancer	3.76e-05	0.000422	CcSEcCtD
Zidovudine—Rash—Docetaxel—pancreatic cancer	3.73e-05	0.000418	CcSEcCtD
Zidovudine—Dermatitis—Docetaxel—pancreatic cancer	3.73e-05	0.000418	CcSEcCtD
Zidovudine—Confusional state—Doxorubicin—pancreatic cancer	3.72e-05	0.000417	CcSEcCtD
Zidovudine—Headache—Docetaxel—pancreatic cancer	3.71e-05	0.000415	CcSEcCtD
Zidovudine—Anaphylactic shock—Doxorubicin—pancreatic cancer	3.69e-05	0.000414	CcSEcCtD
Zidovudine—Oedema—Doxorubicin—pancreatic cancer	3.69e-05	0.000414	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	3.64e-05	0.000408	CcSEcCtD
Zidovudine—Shock—Doxorubicin—pancreatic cancer	3.63e-05	0.000407	CcSEcCtD
Zidovudine—Nervous system disorder—Doxorubicin—pancreatic cancer	3.62e-05	0.000406	CcSEcCtD
Zidovudine—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.62e-05	0.000405	CcSEcCtD
Zidovudine—Insomnia—Epirubicin—pancreatic cancer	3.61e-05	0.000405	CcSEcCtD
Zidovudine—Skin disorder—Doxorubicin—pancreatic cancer	3.59e-05	0.000402	CcSEcCtD
Zidovudine—Paraesthesia—Epirubicin—pancreatic cancer	3.58e-05	0.000402	CcSEcCtD
Zidovudine—Hyperhidrosis—Doxorubicin—pancreatic cancer	3.57e-05	0.0004	CcSEcCtD
Zidovudine—Dyspnoea—Epirubicin—pancreatic cancer	3.56e-05	0.000399	CcSEcCtD
Zidovudine—Somnolence—Epirubicin—pancreatic cancer	3.55e-05	0.000398	CcSEcCtD
Zidovudine—Anorexia—Doxorubicin—pancreatic cancer	3.52e-05	0.000395	CcSEcCtD
Zidovudine—Nausea—Docetaxel—pancreatic cancer	3.51e-05	0.000394	CcSEcCtD
Zidovudine—Dyspepsia—Epirubicin—pancreatic cancer	3.51e-05	0.000394	CcSEcCtD
Zidovudine—Decreased appetite—Epirubicin—pancreatic cancer	3.47e-05	0.000389	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	3.45e-05	0.000386	CcSEcCtD
Zidovudine—Fatigue—Epirubicin—pancreatic cancer	3.44e-05	0.000386	CcSEcCtD
Zidovudine—Constipation—Epirubicin—pancreatic cancer	3.41e-05	0.000383	CcSEcCtD
Zidovudine—Pain—Epirubicin—pancreatic cancer	3.41e-05	0.000383	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	3.36e-05	0.000377	CcSEcCtD
Zidovudine—Insomnia—Doxorubicin—pancreatic cancer	3.34e-05	0.000374	CcSEcCtD
Zidovudine—Paraesthesia—Doxorubicin—pancreatic cancer	3.32e-05	0.000372	CcSEcCtD
Zidovudine—Dyspnoea—Doxorubicin—pancreatic cancer	3.29e-05	0.000369	CcSEcCtD
Zidovudine—Feeling abnormal—Epirubicin—pancreatic cancer	3.29e-05	0.000369	CcSEcCtD
Zidovudine—Somnolence—Doxorubicin—pancreatic cancer	3.28e-05	0.000368	CcSEcCtD
Zidovudine—Gastrointestinal pain—Epirubicin—pancreatic cancer	3.26e-05	0.000366	CcSEcCtD
Zidovudine—Dyspepsia—Doxorubicin—pancreatic cancer	3.25e-05	0.000364	CcSEcCtD
Zidovudine—Decreased appetite—Doxorubicin—pancreatic cancer	3.21e-05	0.00036	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.19e-05	0.000357	CcSEcCtD
Zidovudine—Fatigue—Doxorubicin—pancreatic cancer	3.18e-05	0.000357	CcSEcCtD
Zidovudine—Urticaria—Epirubicin—pancreatic cancer	3.17e-05	0.000355	CcSEcCtD
Zidovudine—Pain—Doxorubicin—pancreatic cancer	3.16e-05	0.000354	CcSEcCtD
Zidovudine—Constipation—Doxorubicin—pancreatic cancer	3.16e-05	0.000354	CcSEcCtD
Zidovudine—Body temperature increased—Epirubicin—pancreatic cancer	3.15e-05	0.000354	CcSEcCtD
Zidovudine—Abdominal pain—Epirubicin—pancreatic cancer	3.15e-05	0.000354	CcSEcCtD
Zidovudine—Feeling abnormal—Doxorubicin—pancreatic cancer	3.04e-05	0.000341	CcSEcCtD
Zidovudine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.02e-05	0.000338	CcSEcCtD
Zidovudine—Urticaria—Doxorubicin—pancreatic cancer	2.93e-05	0.000329	CcSEcCtD
Zidovudine—Abdominal pain—Doxorubicin—pancreatic cancer	2.92e-05	0.000327	CcSEcCtD
Zidovudine—Body temperature increased—Doxorubicin—pancreatic cancer	2.92e-05	0.000327	CcSEcCtD
Zidovudine—Asthenia—Epirubicin—pancreatic cancer	2.86e-05	0.000321	CcSEcCtD
Zidovudine—Pruritus—Epirubicin—pancreatic cancer	2.82e-05	0.000316	CcSEcCtD
Zidovudine—Diarrhoea—Epirubicin—pancreatic cancer	2.73e-05	0.000306	CcSEcCtD
Zidovudine—Asthenia—Doxorubicin—pancreatic cancer	2.65e-05	0.000297	CcSEcCtD
Zidovudine—Dizziness—Epirubicin—pancreatic cancer	2.64e-05	0.000296	CcSEcCtD
Zidovudine—Pruritus—Doxorubicin—pancreatic cancer	2.61e-05	0.000293	CcSEcCtD
Zidovudine—Vomiting—Epirubicin—pancreatic cancer	2.54e-05	0.000284	CcSEcCtD
Zidovudine—Diarrhoea—Doxorubicin—pancreatic cancer	2.53e-05	0.000283	CcSEcCtD
Zidovudine—Rash—Epirubicin—pancreatic cancer	2.52e-05	0.000282	CcSEcCtD
Zidovudine—Dermatitis—Epirubicin—pancreatic cancer	2.51e-05	0.000282	CcSEcCtD
Zidovudine—Headache—Epirubicin—pancreatic cancer	2.5e-05	0.00028	CcSEcCtD
Zidovudine—Dizziness—Doxorubicin—pancreatic cancer	2.44e-05	0.000274	CcSEcCtD
Zidovudine—Nausea—Epirubicin—pancreatic cancer	2.37e-05	0.000266	CcSEcCtD
Zidovudine—Vomiting—Doxorubicin—pancreatic cancer	2.35e-05	0.000263	CcSEcCtD
Zidovudine—Rash—Doxorubicin—pancreatic cancer	2.33e-05	0.000261	CcSEcCtD
Zidovudine—Dermatitis—Doxorubicin—pancreatic cancer	2.33e-05	0.000261	CcSEcCtD
Zidovudine—Headache—Doxorubicin—pancreatic cancer	2.31e-05	0.000259	CcSEcCtD
Zidovudine—Nausea—Doxorubicin—pancreatic cancer	2.19e-05	0.000246	CcSEcCtD
Zidovudine—CYP2C19—Metabolism—ARG2—pancreatic cancer	6.69e-06	9.45e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—KRAS—pancreatic cancer	6.65e-06	9.39e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PPARG—pancreatic cancer	6.65e-06	9.39e-05	CbGpPWpGaD
Zidovudine—TK1—Metabolism—AKT1—pancreatic cancer	6.6e-06	9.32e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TYMP—pancreatic cancer	6.55e-06	9.25e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ARG2—pancreatic cancer	6.53e-06	9.22e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TYMP—pancreatic cancer	6.51e-06	9.2e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TGFB1—pancreatic cancer	6.46e-06	9.13e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	6.35e-06	8.96e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PIK3CB—pancreatic cancer	6.3e-06	8.9e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	6.25e-06	8.83e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTGS2—pancreatic cancer	6.24e-06	8.82e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	6.18e-06	8.73e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CD44—pancreatic cancer	6.15e-06	8.69e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PIK3CA—pancreatic cancer	6.11e-06	8.63e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ARG2—pancreatic cancer	6.1e-06	8.61e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CD44—pancreatic cancer	6.09e-06	8.6e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	6.09e-06	8.6e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CD—pancreatic cancer	6.06e-06	8.55e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PLAU—pancreatic cancer	5.99e-06	8.46e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—KRAS—pancreatic cancer	5.99e-06	8.46e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—HRAS—pancreatic cancer	5.95e-06	8.4e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—pancreatic cancer	5.91e-06	8.35e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GCG—pancreatic cancer	5.9e-06	8.33e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TYMP—pancreatic cancer	5.85e-06	8.26e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GCG—pancreatic cancer	5.84e-06	8.24e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TYMP—pancreatic cancer	5.71e-06	8.06e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	5.67e-06	8.01e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HRAS—pancreatic cancer	5.65e-06	7.99e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—APOE—pancreatic cancer	5.63e-06	7.95e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	5.6e-06	7.91e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CD44—pancreatic cancer	5.59e-06	7.89e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CTNNB1—pancreatic cancer	5.59e-06	7.89e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	5.59e-06	7.89e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—STK11—pancreatic cancer	5.55e-06	7.83e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	5.5e-06	7.77e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—STK11—pancreatic cancer	5.49e-06	7.75e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	5.48e-06	7.74e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTEN—pancreatic cancer	5.45e-06	7.69e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.41e-06	7.63e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.38e-06	7.59e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GCG—pancreatic cancer	5.36e-06	7.57e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TYMP—pancreatic cancer	5.33e-06	7.53e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CG—pancreatic cancer	5.33e-06	7.53e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—pancreatic cancer	5.32e-06	7.51e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GLP1R—pancreatic cancer	5.28e-06	7.46e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CB—pancreatic cancer	5.28e-06	7.45e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—EGF—pancreatic cancer	5.27e-06	7.44e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GLP1R—pancreatic cancer	5.25e-06	7.42e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTGS2—pancreatic cancer	5.23e-06	7.39e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	5.22e-06	7.37e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—DPYD—pancreatic cancer	5.2e-06	7.34e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	5.18e-06	7.31e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—DPYD—pancreatic cancer	5.17e-06	7.3e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—HRAS—pancreatic cancer	5.09e-06	7.19e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CG—pancreatic cancer	5.08e-06	7.17e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—SRC—pancreatic cancer	5.05e-06	7.13e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—STK11—pancreatic cancer	5.04e-06	7.12e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AKT1—pancreatic cancer	4.99e-06	7.05e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	4.93e-06	6.96e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—SLC2A2—pancreatic cancer	4.9e-06	6.92e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PPARG—pancreatic cancer	4.9e-06	6.92e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.88e-06	6.89e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—STAT3—pancreatic cancer	4.87e-06	6.88e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—NRAS—pancreatic cancer	4.86e-06	6.86e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.85e-06	6.85e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	4.83e-06	6.82e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.83e-06	6.81e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—TYMS—pancreatic cancer	4.77e-06	6.74e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	4.75e-06	6.71e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—TYMS—pancreatic cancer	4.72e-06	6.67e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GLP1R—pancreatic cancer	4.71e-06	6.66e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.71e-06	6.65e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CD—pancreatic cancer	4.68e-06	6.62e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.68e-06	6.61e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	4.64e-06	6.55e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—DPYD—pancreatic cancer	4.64e-06	6.55e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GLP1R—pancreatic cancer	4.6e-06	6.5e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	4.6e-06	6.5e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTEN—pancreatic cancer	4.56e-06	6.44e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—DPYD—pancreatic cancer	4.53e-06	6.39e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MYC—pancreatic cancer	4.53e-06	6.39e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TGFB1—pancreatic cancer	4.51e-06	6.38e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—AKT1—pancreatic cancer	4.49e-06	6.35e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CD—pancreatic cancer	4.46e-06	6.3e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EGFR—pancreatic cancer	4.43e-06	6.25e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	4.4e-06	6.21e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.4e-06	6.21e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.35e-06	6.15e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—TYMS—pancreatic cancer	4.33e-06	6.12e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GLP1R—pancreatic cancer	4.3e-06	6.07e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	4.29e-06	6.07e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.29e-06	6.06e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.26e-06	6.02e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—DPYD—pancreatic cancer	4.23e-06	5.97e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.2e-06	5.94e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—KRAS—pancreatic cancer	4.18e-06	5.91e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CB—pancreatic cancer	4.08e-06	5.77e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ARG2—pancreatic cancer	4.02e-06	5.68e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	4.01e-06	5.67e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.97e-06	5.61e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	3.94e-06	5.57e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CB—pancreatic cancer	3.89e-06	5.5e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.88e-06	5.49e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—APOE—pancreatic cancer	3.88e-06	5.48e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTGS2—pancreatic cancer	3.86e-06	5.44e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PIK3CA—pancreatic cancer	3.84e-06	5.43e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—APOE—pancreatic cancer	3.84e-06	5.42e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.83e-06	5.41e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.83e-06	5.41e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CD44—pancreatic cancer	3.82e-06	5.39e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CD44—pancreatic cancer	3.8e-06	5.36e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.74e-06	5.28e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.72e-06	5.25e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.7e-06	5.23e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.68e-06	5.2e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GCG—pancreatic cancer	3.66e-06	5.17e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GCG—pancreatic cancer	3.64e-06	5.14e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HRAS—pancreatic cancer	3.55e-06	5.02e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—APOE—pancreatic cancer	3.52e-06	4.98e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.52e-06	4.97e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CG—pancreatic cancer	3.5e-06	4.94e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.49e-06	4.93e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	3.46e-06	4.89e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—STK11—pancreatic cancer	3.44e-06	4.86e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—STK11—pancreatic cancer	3.42e-06	4.83e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CD44—pancreatic cancer	3.41e-06	4.81e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PPARG—pancreatic cancer	3.38e-06	4.77e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTEN—pancreatic cancer	3.36e-06	4.75e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PPARG—pancreatic cancer	3.34e-06	4.72e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.34e-06	4.71e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CD44—pancreatic cancer	3.33e-06	4.7e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.31e-06	4.67e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—SRC—pancreatic cancer	3.27e-06	4.62e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GCG—pancreatic cancer	3.27e-06	4.61e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.23e-06	4.56e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CA—pancreatic cancer	3.22e-06	4.54e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.21e-06	4.54e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GCG—pancreatic cancer	3.19e-06	4.5e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—VEGFA—pancreatic cancer	3.19e-06	4.5e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	3.18e-06	4.49e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NRAS—pancreatic cancer	3.15e-06	4.45e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—AKT1—pancreatic cancer	3.14e-06	4.43e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CD44—pancreatic cancer	3.11e-06	4.39e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CD—pancreatic cancer	3.08e-06	4.35e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—STK11—pancreatic cancer	3.07e-06	4.34e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PPARG—pancreatic cancer	3.07e-06	4.34e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	3.05e-06	4.3e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.04e-06	4.3e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.01e-06	4.26e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—STK11—pancreatic cancer	3e-06	4.23e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GCG—pancreatic cancer	2.98e-06	4.21e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TYMS—pancreatic cancer	2.96e-06	4.18e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TYMS—pancreatic cancer	2.94e-06	4.16e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TGFB1—pancreatic cancer	2.92e-06	4.13e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.88e-06	4.07e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.83e-06	4e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—STK11—pancreatic cancer	2.8e-06	3.96e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	2.8e-06	3.95e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.79e-06	3.94e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—KRAS—pancreatic cancer	2.71e-06	3.83e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CB—pancreatic cancer	2.68e-06	3.79e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTGS2—pancreatic cancer	2.66e-06	3.75e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	2.65e-06	3.75e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.65e-06	3.74e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TYMS—pancreatic cancer	2.64e-06	3.73e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTGS2—pancreatic cancer	2.63e-06	3.72e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.63e-06	3.71e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—AKT1—pancreatic cancer	2.63e-06	3.71e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TYMS—pancreatic cancer	2.58e-06	3.64e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CA—pancreatic cancer	2.49e-06	3.52e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	2.44e-06	3.44e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS2—pancreatic cancer	2.41e-06	3.41e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TYMS—pancreatic cancer	2.41e-06	3.4e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—pancreatic cancer	2.41e-06	3.4e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—APOE—pancreatic cancer	2.41e-06	3.4e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—APOE—pancreatic cancer	2.39e-06	3.38e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	2.37e-06	3.35e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTEN—pancreatic cancer	2.32e-06	3.27e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HRAS—pancreatic cancer	2.3e-06	3.25e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTEN—pancreatic cancer	2.29e-06	3.24e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.28e-06	3.22e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.27e-06	3.2e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	2.17e-06	3.07e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CG—pancreatic cancer	2.16e-06	3.05e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—APOE—pancreatic cancer	2.15e-06	3.03e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTEN—pancreatic cancer	2.11e-06	2.97e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—APOE—pancreatic cancer	2.1e-06	2.96e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.1e-06	2.96e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PPARG—pancreatic cancer	2.09e-06	2.94e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CD44—pancreatic cancer	2.05e-06	2.89e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.03e-06	2.87e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—AKT1—pancreatic cancer	2.03e-06	2.87e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GCG—pancreatic cancer	1.96e-06	2.77e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—APOE—pancreatic cancer	1.96e-06	2.77e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	1.94e-06	2.74e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AKT1—pancreatic cancer	1.94e-06	2.74e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	1.91e-06	2.7e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CD—pancreatic cancer	1.9e-06	2.68e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	1.89e-06	2.67e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PPARG—pancreatic cancer	1.87e-06	2.64e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.85e-06	2.62e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—STK11—pancreatic cancer	1.85e-06	2.61e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PPARG—pancreatic cancer	1.83e-06	2.58e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	1.77e-06	2.5e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PPARG—pancreatic cancer	1.71e-06	2.41e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.7e-06	2.41e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	1.66e-06	2.35e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	1.66e-06	2.35e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CB—pancreatic cancer	1.66e-06	2.34e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	1.65e-06	2.33e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS2—pancreatic cancer	1.64e-06	2.32e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CA—pancreatic cancer	1.64e-06	2.31e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	1.62e-06	2.29e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.59e-06	2.24e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.55e-06	2.2e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.49e-06	2.1e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	1.49e-06	2.1e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.47e-06	2.08e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.45e-06	2.05e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.44e-06	2.03e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.44e-06	2.03e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTEN—pancreatic cancer	1.43e-06	2.02e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.35e-06	1.91e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.34e-06	1.9e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AKT1—pancreatic cancer	1.34e-06	1.89e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AKT1—pancreatic cancer	1.32e-06	1.87e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—APOE—pancreatic cancer	1.29e-06	1.82e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.28e-06	1.81e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTEN—pancreatic cancer	1.25e-06	1.77e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AKT1—pancreatic cancer	1.21e-06	1.71e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.17e-06	1.65e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.17e-06	1.65e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.13e-06	1.59e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.03e-06	1.45e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.01e-06	1.43e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CA—pancreatic cancer	1.01e-06	1.43e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	9.06e-07	1.28e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	8.94e-07	1.26e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	8.85e-07	1.25e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	8.84e-07	1.25e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKT1—pancreatic cancer	8.29e-07	1.17e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	8.26e-07	1.17e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKT1—pancreatic cancer	8.24e-07	1.16e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTEN—pancreatic cancer	7.72e-07	1.09e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKT1—pancreatic cancer	7.4e-07	1.05e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKT1—pancreatic cancer	7.22e-07	1.02e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKT1—pancreatic cancer	6.75e-07	9.53e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	5.45e-07	7.69e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.45e-07	6.28e-06	CbGpPWpGaD
